Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215611 · ClinicalTrials.gov registry record
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
A clinical trial of Financial Toxicity and Bone Sarcomas, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07215611: Recruiting study of Financial Toxicity and Bone Sarcomas, sponsored by M.D. Anderson Cancer Center.
NCT07215611 is a study of Financial Toxicity and Bone Sarcomas that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, above the 78-participant average among 5 other Financial Toxicity trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215611, a study of Financial Toxicity and Bone Sarcomas, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
Conditions Studied
Interventions
- OTHER data collection
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2030-10-02 |
What NCT07215611 shows while recruiting
NCT07215611 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 5 other Financial Toxicity trials with a reported enrollment target (28% higher).
The record links to 2 conditions, with Financial Toxicity appearing as the primary indexed condition, and to 1 intervention - of which data collection is the first listed.
NCT07215611 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07215611 about?
NCT07215611 is a clinical study titled "Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas". To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
What is the current status of trial NCT07215611?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-02. Estimated completion is 2030-10-02.
What conditions does trial NCT07215611 study?
This clinical trial studies the following conditions: Financial Toxicity, Bone Sarcomas.
What interventions are being tested in trial NCT07215611?
The interventions under investigation include: data collection (OTHER).
Who is sponsoring clinical trial NCT07215611?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215611 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Financial Toxicity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Proactive Costs of Care Study
RECRUITING · NA
-
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
RECRUITING · NA
-
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
RECRUITING · NA
-
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
RECRUITING · NA
-
Feasibility and Utilization of an Application-based Question Prompt List
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI